Clinical Roundup SU2C, Johnson & Johnson collaborate on research project focused on rare disease linked to blood cancers November 15, 2024Vol.50 No.43
Clinical Roundup Stanford Medicine-led team uncovers potential therapy based on extrachromosomal DNA research November 15, 2024Vol.50 No.43
Clinical Roundup Phase I clinical trial of Keytruda + Lymphir for recurrent solid tumors yields positive preliminary results November 15, 2024Vol.50 No.43
Clinical Roundup USC study identifies innate immune system protein as potential target for CRC immunotherapy November 15, 2024Vol.50 No.43
Clinical Roundup Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection November 15, 2024Vol.50 No.43
Clinical Roundup Wugen launches phase II study of CD7-targeted CAR T for r/r T-ALL or T-ALL/LBL November 15, 2024Vol.50 No.43
Drugs & Targets FDA approves Aucatzyl for adults with r/r B-cell precursor ALL November 15, 2024Vol.50 No.43
Drugs & Targets Tempus, Flatiron collaborate to expand point of care through OncoEMR integration November 15, 2024Vol.50 No.43
Drugs & Targets Humana and Evolent expand partnership to enhance oncology care November 15, 2024Vol.50 No.43
